Likert pain score modeling: A markov integer model and an autoregressive continuous model

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 5, 2012, Pages 820-828

  Plan, E L ^a   Elshoff, J P ^b   Stockis, A ^b   Sargentini Maier, M L ^b,c   Karlsson, M O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UCB PHARMA   (Belgium)

^c ABLYNX NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; LIKERT PAIN SCORE MODELING; MALE; MATHEMATICAL MODEL; NEUROPATHIC PAIN; PAIN ASSESSMENT; PLACEBO EFFECT; POISSON DISTRIBUTION; PRIORITY JOURNAL; PROBABILITY; SAMPLING ERROR;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, STATISTICAL; PAIN MEASUREMENT; PROBABILITY;

EID: 84859978643     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.301     Document Type: Article

References (44)

1. Scholz, J. & Woolf, C.J. Can we conquer pain? Nat. Neurosci. 5 (suppl.), 1062-1067 (2002).
2. Eisenberg, E., Lurie, Y., Braker, C., Daoud, D. & Ishay, A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 57, 505-509 (2001).
3. Backonja, M. et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280, 1831-1836 (1998).
4. Rosenstock, J., Tuchman, M., LaMoreaux, L. & Sharma, U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110, 628-638 (2004).
5. McCaffery, M. & Beebe, A. Pain: Clinical Manual for Nursing Practice (V.V. Mosby, Baltimore, MD, 1993).
6. Tesfaye, S. & Kempler, P. Painful diabetic neuropathy. Diabetologia 48, 805-807 (2005).
7. Juergensen, E., Wuerth, D., Finkelstein, S.H., Juergensen, P.H., Bekui, A. & Finkelstein, F.O. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin. J. Am. Soc. Nephrol. 1, 1191-1196 (2006).
8. Grilo, R.M., Treves, R., Preux, P.M., Vergne-Salle, P. & Bertin, P. Clinically relevant VAS pain score change in patients with acute rheumatic conditions. Joint Bone Spine 74, 358-361 (2007).
9. Rudwaleit, M., Listing, J., Brandt, J., Braun, J. & Sieper, J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann. Rheum. Dis. 63, 665-670 (2004).
10. Sheiner, B.L. & Beal, S.L. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J. Pharmacokinet. Biopharm. 9, 635-651 (1981).
11. Sheiner, L.B. & Beal, S.L. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. J. Pharmacokinet. Biopharm. 8, 553-571 (1980).
12. Sheiner, L.B. & Beal, S.L. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data. J. Pharmacokinet. Biopharm. 11, 303-319 (1983).
13. Sheiner, L.B., Rosenberg, B. & Marathe, V.V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J. Pharmacokinet. Biopharm. 5, 445-479 (1977).
14. Vonesh, E.F. Non-linear models for the analysis of longitudinal data. Stat. Med. 11, 1929-1954 (1992).
15. A bou Hammoud, H., Simon, N., Urien, S., Riou, B., Lechat, P. & Aubrun, F. Intravenous morphine titration in immediate postoperative pain management: population kinetic-pharmacodynamic and logistic regression analysis. Pain 144, 139-146 (2009).
16. A asvang, E.K. et al. The effect of wound instillation of a novel purified capsaicin formulation on postherniotomy pain: a double-blind, randomized, placebo-controlled study. Anesth. Analg. 107, 282-291 (2008).
17. Olofsen, E. et al. Alfentanil and placebo analgesia: no sex differences detected in models of experimental pain. Anesthesiology 103, 130-139 (2005).
18. Shafer, S.L., Eisenach, J.C., Hood, D.D. & Tong, C. Cerebrospinal fluid pharmacokinetics and pharmacodynamics of intrathecal neostigmine methylsulfate in humans. Anesthesiology 89, 1074-1088 (1998).
19. Mandema, J.W. & Stanski, D.R. Population pharmacodynamic model for ketorolac analgesia. Clin. Pharmacol. Ther. 60, 619-635 (1996).
20. A nderson, B.J., Holford, N.H., Woollard, G.A., Kanagasundaram, S. & Mahadevan, M. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology 90, 411-421 (1999).
21. Byon, W. et al. Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change. J. Clin. Pharmacol. 50, 803-815 (2010).
22. Molas, M. & Lesaffre, E. A comparison of three random effects approaches to analyze repeated bounded outcome scores with an application in a stroke revalidation study. Stat. Med. 27, 6612-6633 (2008).
23. Hu, C., Yeilding, N., Davis, H.M. & Zhou, H. Bounded outcome score modeling: application to treating psoriasis with ustekinumab. J. Pharmacokinet. Pharmacodyn. 38, 497-517 (2011).
24. Lesaffre, E., Rizopoulos, D. & Tsonaka, R. The logistic transform for bounded outcome scores. Biostatistics 8, 72-85 (2007).
25. Gupta, S.K., Sathyan, G., Lindemulder, E.A., Ho, P.L., Sheiner, L.B. & Aarons, L. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships. Clin. Pharmacol. Ther. 65, 672-684 (1999).
26. Miller, R. et al. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Clin. Pharmacol. Ther. 73, 491-505 (2003).
27. Coghill, R.C. Individual differences in the subjective experience of pain: new insights into mechanisms and models. Headache 50, 1531-1535 (2010).
28. Silber, H.E., Kjellsson, M.C. & Karlsson, M.O. The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion. J. Pharmacokinet. Pharmacodyn. 36, 81-99 (2009).
29. Karlsson, M.O., Beal, S.L. & Sheiner, L.B. Three new residual error models for population PK/PD analyses. J. Pharmacokinet. Biopharm. 23, 651-672 (1995).
30. Deltour, I., Richardson, S. & Le Hesran, J.Y. Stochastic algorithms for Markov models estimation with intermittent missing data. Biometrics 55, 565-573 (1999).
31. Sheiner, L.B. Learning versus confirming in clinical drug development. Clin. Pharmacol. Ther. 61, 275-291 (1997).
32. Wymer, J.P., Simpson, J., Sen, D. & Bongardt, S. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin. J. Pain 25, 376-385 (2009).
33. Ziegler, D. et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care 33, 839-841 (2010).
34. Shaibani, A. et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J. Pain 10, 818-828 (2009).
35. Beal, S., Sheiner, L.B., Boeckmann, A., & Bauer, R.J. NONMEM User's Guides (Icon Development Solutions, Ellicott City, MD, 1989-2009).
36. Karlsson, M.O. & Holford, N.H.G. A tutorial on visual predictive checks. In Population Approach Group in Europe, PAGE 17 (2008).
37. Hooker, A.C., Staatz, C.E. & Karlsson, M.O. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method. Pharm. Res. 24, 2187-2197 (2007).
38. Lindbom, L., Pihlgren, P., Jonsson, E.N. & Jonsson, N. PsN-Toolkit - a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput. Methods Programs Biomed. 79, 241-257 (2005).
39. Jonsson, E.N. & Karlsson, M.O. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput. Methods Programs Biomed. 58, 51-64 (1999).
40. Plan, E.L., Maloney, A., Trocóniz, I.F. & Karlsson, M.O. Performance in population models for count data, part I: maximum likelihood approximations. J. Pharmacokinet. Pharmacodyn. 36, 353-366 (2009).
41. Consul, P. Generalized Poisson Distributions: Properties and Applications (Marcel Dekker, New York, 1989).
42. Gschlossl, S. & Czado, C. Modelling count data with overdispersion and spatial effects. Statistical Papers 49, 531-552 (2008).
43. Ramanujan, S. The Lost Notebook and Other Unpublished Papers (Springer, Berlin, Germany, 1988).
44. Davidian, M. & Giltinan, D.M. Some general estimation methods for nonlinear mixed-effects models. J. Biopharm. Stat. 3, 23-55 (1993).